ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Key Cancer Legislation Remains Unfinished as Congress Departs for Election.

October 6, 2006

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

Former NCI Executive Lands Key Senate Staff Position

February 4, 1977

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

Fredrickson, Upton Kill Plan To Convert FCRC To NIH Satellite, Will Continue L-B Contract

February 9, 1979

NRSAs Renamed For Kirschstein.

June 21, 2002